So far Italy has barely registered on the roster of biotech nations. Now that is set to change as the first biotechnology champions emerge and the country goes all out to attract inward investment.
Three new centres for systems biology are to be launched with funding of £27 million from the UK’s Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council.
A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer
Researchers are taking cues from a century-old spray drying technology to see if it could be developed to make better products for the food and pharmaceutical industries. They are now looking for investors and partnership from industry players.
The inventors of an imaging system to improve diagnosis of coronary heart disease are looking at licensing the technology – or getting venture capital to create a spin-out.
A researcher at the Academic Medical Centre in Amsterdam has developed instruments that could assist surgeons to perform keyhole surgery. The centre is now looking for investors and partnership or licensing agreements for the technology.
The conclusion that there was nothing wrong with the specifics of the TeGenero trial in which six healthy volunteers ended up in intensive care has repercussions for the wider biotech industry.
What happens to the company labs when there’s a merger? That’s the question many in the telecoms industry are now asking, following news of merger plans by US-based Lucent and France's Alcatel.
A University of Plymouth graduate has invented a machine that combines washing, drying and ironing functions with the touch of a button, and he is now looking for investment of up to £5 million to refine the product for the general household use.
Chroma Therapeutics Ltd raised £30 million in a third private round, giving the chromatin specialist funding for the next three years and enabling it to advance the lead programme through Phase II clinical studies and bring two further products into the clinic.
Johnson & Johnson's Corporate Office of Science & Technology (COSAT) has agreed to fund a research programme on hearing loss conduced by University College London's (UCL) Ear Institute under a partnership between the pharmaceutical giant and RNID, a non-profit organisation for the hearing impaired in the UK.
After finding nothing wrong with the specifics of the preclinical data, the product, or how the trial was conducted, the UK Medicines and Healthcare Products Regulatory Agency has ordered an investigation to changes in clinical trials procedures.
Israeli researchers have invented software to “freeze” an image of the human heart in order to facilitate catheter navigation. They are now looking for either an investment or a licensing deal for the technology.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.